Reading, engaging with, and sharing our publications, papers and commentary gives evidence-based science and policy the audience it needs and deserves.
By checking this box I consent to the use of my information provided for email marketing purposes.
In each episode Prof. David Nutt is joined by leading experts to discuss research, harm reduction, drug policy, and the science behind drugs
The World's Biggest Placebo-Controlled Microdosing Study
Psychedelics and the Brain - In My Professional Opinion
Psychedelics and Nature Connection - In My Professional Opinion
Ethical Implications of Psychedelics
Building a Career in Drug Science
Psychological Support in Psilocybin Therapy - In My Professional Opinion
Psilocybin for Anorexia Nervosa
Psilocybin Therapy for Depression - Clinical Insights
MDMA for Alcohol Use Disorder
Women in Psychedelic Science - Part 3
What would a regulated stimulant market look like?
Investing in Psychedelic Companies
Psilocybin Treatment for Depression - Clinical Insights
Psilocybin Treatment for Depression - Patient Perspective
Street Drug Discussions - Deep Dive into Alcohol
In My Professional Opinion - Vaping and Tobacco Harm Reduction